Erratum: Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: A case - Control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium (Leukemia (2012) 26 (1419-1422) DOI: 10.1038/leu.2011.352);Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: A case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium

Leukemia

Volumn 26, Issue 6, 2012, Pages 1419-1422

  Martino, A ^a   Campa, D ^a   Buda, G ^b   Sainz, J ^c,d   Garcia Sanz R ^e   Jamroziak, K ^f   Reis, R M ^g,h   Weinhold, N ⁱ   Jurado, M ^c,d   Rios R ^c,d   Szemraj Rogucka, Z ^f   Marques, H ^g   Szemraj, J ^f   Stein, A ^a   Kumar, R ^a   Orciuolo, E ^b   Gemignani, F ^b   Landi, S ^b   Goldschmidt, H ⁱ   Petrini, M ^b   Dumontet, C ^j   Canzian, F ^a   Rossi, A M ^b   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF GRANADA   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^e HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^f MEDICAL UNIVERSITY OF LODZ   (Poland)

^g UNIVERSITY OF MINHO   (Portugal)

^h BARRETOS CANCER HOSPITAL   (Brazil)

ⁱ UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^j UNIVERSITÉ LYON 1   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN ABCC1; PROTEIN ABCC2; PROTEIN ABCC3; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

CANCER RISK; CANCER SUSCEPTIBILITY; DOWNSTREAM PROCESSING; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HIGH RISK PATIENT; HUMAN; LETTER; MULTIPLE MYELOMA; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84862021696     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2013.146     Document Type: Erratum

References (15)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 (Internet). 2010. (cited; available from: http://globocan.iarc.fr).
2. Landgren O, Weiss BM. Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis. Leukemia 2009; 23: 1691-1697.
3. Hayden PJ, Tewari P, Morris DW, Staines A, Crowley D, Nieters A et al. Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma. Hum Mol Genet 2007; 16: 3117-3127. (Pubitemid 350131330)
4. Zintzaras E, Giannouli S, Rodopoulou P, Voulgarelis M. The role of MTHFR gene in multiple myeloma. J Hum Genet 2008; 53: 499-507.
5. Singh MS, Michael M. Role of xenobiotic metabolic enzymes in cancer epidemiology. Methods Mol Biol 2009; 472: 243-264.
6. Tang L, Bergevoet SM, Gilissen C, de Witte T, Jansen JH, van der Reijden BA et al. Hematopoietic stem cells exhibit a specific ABC transporter gene expression profile clearly distinct from other stem cells. BMC Pharmacol 2010; 10: 12.
7. Landgren O, Kyle RA, Hoppin JA, Beane Freeman LE, Cerhan JR, Katzmann JA et al. Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study. Blood 2009; 113: 6386-6391.
8. Lope V, Perez-Gomez B, Aragones N, Lopez-Abente G, Gustavsson P, Plato N et al. Occupation, exposure to chemicals, sensitizing agents, and risk of multiple myeloma in Sweden. Cancer Epidemiol Biomarkers Prev 2008; 17: 3123-3127.
9. Leal-Ugarte E, Gutierrez-Angulo M, Macias-Gomez NM, Peralta-Leal V, Duran-Gonzalez J, De La Luz Ayala-Madrigal M et al. MDR1 C3435T polymorphism in Mexican children with acute lymphoblastic leukemia and in healthy individuals. Hum Biol 2008; 80: 449-455.
10. Urayama KY, Wiencke JK, Buffler PA, Chokkalingam AP, Metayer C, Wiemels JL. MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 2007; 16: 1172-1177. (Pubitemid 46984955)
11. Jamroziak K, Balcerczak E, Calka K, Piaskowski S, Urbanska-Rys H, Salagacka A et al. Polymorphisms and haplotypes in the multidrug resistance 1 gene (MDR1/ABCB1) and risk of multiple myeloma. Leuk Res 2009; 33: 332-335.
12. Krupoves A, Seidman EG, Mack D, Israel D, Morgan K, Lambrette P et al. Associations between ABCB1/MDR1 gene polymorphisms and Crohn0s disease: a gene-wide study in a pediatric population. Inflamm Bowel Dis 2009; 15: 900-908.
13. Yuan HY, Chiou JJ, Tseng WH, Liu CH, Liu CK, Lin YJ et al. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 2006; 34(Web Server issue): W635-641.
14. Lecuyer E, Hoang T. SCL: from the origin of hematopoiesis to stem cells and leukemia. Exp Hematol 2004; 32: 11-24. (Pubitemid 38064397)
15. Palii CG, Perez-Iratxeta C, Yao Z, Cao Y, Dai F, Davison J et al. Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages. EMBO J 2010; 30: 494-509.